Untitled Document
OHSU Where Healing, Teaching and Discovery Come Together
OHSU Search OHSU OHSU Site Map Contact
OHSU Division of Hematology and Medical Oncology
About the Division Care Centers Patient Resources Our Faculty Research and Education News and Events
Dedicated to the study and treatment of cancer and disorders of the blood.

 

OHSU Cancer Institute Expert to be Featured in National Non-Hodgkin's Lymphoma Education Program

WHAT:
Oregon Health & Science University Cancer Institute non-Hodgkin’s lymphoma expert Craig Nichols, M.D., will be the featured speaker in a free educational program sponsored by The Leukemia & Lymphoma Society. The program is designed for patients, caregivers, and health care professionals and will cover the diagnosis and treatment of NHL, established therapies, the role of clinical trials in the advancement of treatment and quality-of-life issues. This program is part of The Society’s Insights into Non-Hodgkin Lymphoma (NHL) telephone education series.

Nichols serves as head of the Division of Hematology/Medical Oncology in the Oregon Health & Science University School of Medicine, and is associate director of the OHSU Cancer Institute.

WHEN:
Wednesday, May 10, 2006; 10 a.m.- 11 a.m. Pacific Time

DETAILS:
Register for the program, which is available by conference call, by visiting http://lls.org/lymphomaeducation
or calling 866 992-9950, ext. 304. Continuing education credit is available for nurses and social workers. More information is available through The Society’s Information Resource Center at 800 955-4572.

The OHSU Cancer Institute is the only National Cancer Institute-designated cancer center between Sacramento and Seattle.  It comprises some 200 clinical researchers and basic scientists who work together to translate scientific understanding into longer and better lives for Oregon’s cancer patients. Visit ohsucancer.com for more information about the OHSU Cancer Institute.

The Leukemia & Lymphoma Society is the world's largest voluntary health organization dedicated to funding blood cancer research and providing education and patient services. The Society's mission: Cure leukemia, lymphoma, Hodgkin's disease and myeloma, and improve the quality of life of patients and their families. Since its founding in 1949, the society has invested more than $424 million in research specifically targeting leukemia, lymphoma and myeloma.